Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Health Quality Ontario. Pharmacogenomic testing for psychotropic medication selection: a systematic review of the Assurex GeneSight Psychotropic test. Toronto: Health Quality Ontario (HQO). Ontario Health Technology Assessment Series; 17(4). 2017 Authors' conclusions There is uncertainty about the use of GeneSight Psychotropic pharmacogenomic genetic panel
to guide medication selection. It was associated with improvements in some patient outcomes,
but not others. As well, our confidence in these findings is low because of limitations in the body
of evidence. Indexing Status Subject indexing assigned by CRD MeSH Humans; Pharmacogenetics; Pharmacogenomic Testing; Psychotropic Drugs Language Published English Country of organisation Canada English summary An English language summary is available. Address for correspondence Evidence Development and Standards, Health Quality Ontario, 130 Bloor Street West, 10th floor, Toronto, Ontario Canada M5S 1N5 Email: EDSinfo@hqontario.ca AccessionNumber 32017000240 Date abstract record published 24/04/2017 |